Quantcast
How Far Urine Flows In A Tiny Tube Says A Lot About Your

How Far Urine Flows In A Tiny Tube Says A Lot About Your Health

Provided by Brigham Young University Innovative device detects prostate cancer, kidney disease on the spot When you flush the toilet, you may be discarding microscopic warning signs about your health. But a cunningly simple new device can...

Latest Prostate Stories

2014-10-28 12:30:57

SANTA MONICA, Calif., Oct. 28, 2014 /PRNewswire-USNewswire/ -- The Prostate Cancer Foundation (PCF), with funding from the Movember Foundation, proudly announces an innovative program called the Movember Foundation-PCF Scientific Reproducibility Initiative. Due to reports of issues related to the reproducibility of high-impact biomedical research findings, this initiative will assess the reproducibility of research findings with implications for prostate cancer patients. "The...

2014-10-27 12:30:47

Men deserve to know where they stand to have a fighting chance and with early detection, the survival rate for prostate cancer can be over 90 per cent TORONTO, Oct. 27, 2014 /CNW/ - Prostate Cancer Canada responds today to guidelines released from The Canadian Task Force on Preventive Health Care (CTFPHC) recommending that the Prostate Specific Antigen (PSA) test should be eliminated as a screening tool for prostate cancer. Prostate Cancer Canada disagrees with the recommendations and wants...

2014-10-27 12:30:42

Task Force says harms of PSA screening outweigh the benefits OTTAWA, Oct. 27, 2014 /CNW/ - Today the Canadian Task Force on Preventive Health Care (CTFPHC) released an updated guideline on screen­ing for prostate cancer using the prostate specific antigen (PSA) test. Based on the balance between the possible benefits and potential harms of early diagnosis and treatment of prostate cancer, the CTFPHC recommends not screening for prostate cancer with the PSA test. Guidelines are published in...

2014-10-21 08:34:00

NEW YORK, Oct. 21, 2014 /PRNewswire/ -- Honoring one's Hispanic heritage is about more than just celebrating your roots, it is about bringing awareness of issues that affect your community. Prostate cancer is the most common cancer among Hispanic man, affecting 1-in-7 during their lifetime. Dr. David Samadi, chief of urology at Lennox Hill Hospital in New York City, is urging Latin women to have the men in their lives get a simple blood test as a way to screen their prostate health....

2014-10-17 00:21:14

SAN DIEGO, Oct. 16, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced that a draft local coverage determination (LCD) for its Decipher® Prostate Cancer Classifier has been published by the Centers for Medicare and Medicaid Services (CMS) describing a coverage and payment policy for use of the Decipher test in men who have undergone radical prostatectomy. An LCD is a decision by Medicare contractors to cover an item or service. Decipher is the only genomic test for prostate...

2014-10-14 12:29:42

WASHINGTON, Oct. 14, 2014 /PRNewswire-USNewswire/ -- ZERO - The End of Prostate Cancer recently awarded the Jim Lafferty Memorial Research Grant in the amount of $45,000 to Peter Carroll, M.D., M.P.H., of UC San Francisco for the purpose of researching new and improved methods for early detection of prostate cancer. The grant is part of the ZERO Cancer Research Fund, charged with supporting innovative, high-reward research that offers the best return on investment for patients and...

2014-10-09 08:27:36

ProMark(TM) Validated to Predict Disease Aggressiveness and Empower Informed Treatment Decisions CAMBRIDGE, Mass., Oct. 9, 2014 /PRNewswire/ -- Metamark announced today the nationwide availability of ProMark(TM), the first-of-its-kind protein-based biopsy test designed to improve the accuracy of prognosis for men diagnosed with prostate cancer. For the 205,000 men annually with indeterminate Gleason scores (3+3 and 3+4), ProMark can help identify aggressiveness of the disease....

2014-10-02 08:29:14

Study will assess ability of VolitionRx NuQ® to distinguish between aggressive anaplastic prostate cancer and typical castration-resistant prostate cancer (CRPC) NAMUR, Belgium, Oct. 2, 2014 /PRNewswire/ --VolitionRx Limited (OTCQB: VNRX), a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today announced a study collaboration with The University of Texas MD Anderson Cancer Center's Department of Genitourinary Medical Oncology. The study...

2014-09-30 08:32:22

Trelstar® one-, three-, and six-month dosing options now available TORONTO and LAUSANNE, Switzerland, September 30, 2014 /PRNewswire/ -- Trelstar(R) (triptorelin pamoate), indicated in Canada for the palliative treatment of hormone dependent advanced prostate cancer,[1] is now available in a six-month dosing option (22.5 mg). The new dosing option eases the burden on patients, with a decreased number of injections and a low incidence of injection site pain, while providing...

2014-09-30 08:30:47

Prostate Cancer Canada grant aims to accelerate pace of discovery of novel therapies TORONTO, Sept. 30, 2014 /CNW/ - Prostate Cancer Canada is in a race to give the approximately 24,000 Canadian men diagnosed with prostate cancer each year a better fighting chance. In response to the urgent need to increase the pace of discovery, Prostate Cancer Canada just awarded a Translation Acceleration Grant (TAG) to a team led by Dr. Paul Rennie of the Vancouver Prostate Centre and the...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
ambsace
  • Bad luck; misfortune.
  • The smallest amount possible or the most worthless thing.
The word 'ambsace' comes from a Latin word meaning 'both'.